Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tissue microarrays enabling high-throughput molecular pathology.

Mikiko Takikita1, Joon-Yong Chung, Stephen M Hewitt

  • 1Tissue Array Research Program, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, TARP Lab, MSC 4605, Bethesda, MD 20892-4605, USA.

Current Opinion in Biotechnology
|July 24, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of novel GPC2-directed radiotheranostics and CAR T cell therapy for neuroblastoma.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Ablation of glypican-3 enhances radiosensitivity in liver cancer by prolonging G2/M arrest and activating the ATM/CHK2 pathway.

bioRxiv : the preprint server for biology·2026
Same author

Nuclear Galectin-1 Drives Cancer Progression through <i>O</i>-GlcNAcylation-Dependent Regulation of SOX2.

International journal of biological sciences·2026
Same author

A Novel CD147-Targeting Nanobody for Immuno-PET Imaging of Liver Cancer.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same author

Clinical and Functional Characterization of PDE1A as a Wnt/<b>β</b>-Catenin-Linked Biomarker of Progression and Platinum Resistance in Epithelial Ovarian Cancer.

Oncology research·2026
Same author

Tetraspanin-8 as a Tumor-Selective Immuno-PET Target in Hepatocellular Carcinoma.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2025
Same journal

Microbial C1 assimilation pathways for chemical synthesis: from native metabolism to synthetic design.

Current opinion in biotechnology·2026
Same journal

Medicinal plants fermentation: current knowledge and perspectives.

Current opinion in biotechnology·2026
Same journal

Fermented foods: lessons learned from metagenomics.

Current opinion in biotechnology·2026
Same journal

Microfluidic platforms for the transient transfection of mammalian cells: recent developments and challenges.

Current opinion in biotechnology·2026
Same journal

Harvesting insights from recent advances in yeast genomics for predictable and precision wine fermentation.

Current opinion in biotechnology·2026
Same journal

Minimal enzyme cascades for the aromatic-to-aromatic upgrading of lignin monomers.

Current opinion in biotechnology·2026
See all related articles

Tissue microarrays revolutionize pathology by enabling high-throughput analysis of numerous samples on a single slide. This method shifts focus from histomorphology to molecular characterization, improving biomarker studies and tissue analysis quality.

Area of Science:

  • Pathology
  • Biomarker Discovery
  • Molecular Diagnostics

Background:

  • Traditional slide review is time-consuming and lacks reproducibility for large sample sets.
  • Tissue microarrays (TMAs) offer a solution for high-throughput analysis of multiple tissue specimens.
  • Advancements in pathology are shifting towards molecular characterization over traditional histomorphology.

Purpose of the Study:

  • To highlight the paradigm shift in pathology introduced by tissue microarrays.
  • To underscore the utility of TMAs in high-throughput molecular analysis and biomarker studies.
  • To emphasize the critical role of tissue quality and handling in TMA-based research.

Main Methods:

  • Tissue microarrays enable the consolidation of tens to hundreds of tissue samples onto a single slide.

Related Experiment Videos

  • This platform facilitates the review of a single stain across numerous specimens simultaneously.
  • TMAs support both immunohistochemistry for molecular characterization and retained histomorphology analysis.

    • Main Results:

    • TMAs significantly enhance throughput for pathological assessments and biomarker studies.
    • The platform allows for large-scale retrospective clinical studies correlating biomarkers with patient outcomes.
    • TMAs are applicable to high-throughput analysis of cell lines and xenografts, expanding research capabilities.

    Conclusions:

    • Tissue microarrays represent a significant advancement, enabling efficient, reproducible, and high-throughput pathological analysis.
    • This technology facilitates molecular characterization and biomarker discovery, driving progress in personalized medicine.
    • Ensuring high-quality tissue and optimized handling is paramount for reliable data generation in TMA studies.